Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma

Fig. 3

Radiomics signature and hematology model predictive performance. A: Radiomics signature value bar plot for every ESCC patient. The optimal threshold value for distinguishing among cohorts with non-pCR versus pCR is -0.151. B: Comparison of radScore among non-pCR versus pCR cohorts (P < 0.001). C: Hematology model value bar plot for every ESCC patient. The optimal threshold value for distinguishing among cohorts with non-pCR versus pCR is -0.933. D: Comparison of hemScore among non-pCR versus pCR cohorts (P < 0.001). The green color in the figure represents non-pCR patients, while the blue color represents pCR patients

Back to article page